Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Immunology Letters|June 13, 2006
Characterization of murine CD160+ CD8+ T lymphocytesKunio Tsujimura, Yuichi Obata, Yasue Matsudaira, et al.Human Immunology|June 29, 2013
An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 moleculesShinji Kondo, Ayako Demachi-Okamura, Tomoya Hirosawa, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Zoledronate sensitizes neuroblastoma-derived tumor-initiating cells to cytolysis mediated by human γδ T cellsNobuhiro Nishio, Mitsugu Fujita, Yoshimasa Tanaka, et al.Cancer Genetics|March 23, 2025
Immune prognostic model for glioblastoma based on the ssGSEA enrichment scoreTakanari Okamoto, Ryo Mizuta, Ayako Demachi-Okamura, et al.International Journal of Hematology|June 13, 2023
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantationCarolyne Barakat, Yuichiro Inagaki, Shohei Mizuno, et al.Cancer Science|April 7, 2011
Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantationTomoya Hirosawa, Hiroki Torikai, Mayumi Yanagisawa, et al.Translational Lung Cancer Research|October 24, 2025
The difference in tumor immune microenvironment and IFN-γ response between solid and non-solid adenocarcinomaShuichi Shinohara, Daisuke Muraoka, Ayako Demachi-Okamura, et al.Gynecologic Oncology|October 16, 2024
Immunological impact of intraperitoneal and intravenous chemotherapy in ovarian cancer, translational analyses of the Phase 3 iPocc trialAiko Ogasawara, Hirokazu Matsushita, Tuan Zea Tan, et al.Cellular Immunology|January 7, 2026
Functional and structural analysis of KK-LC-1-specific T cell receptors from patients with lung Cancer for immunotherapyYasunori Fukushima, Yizheng Wang, Yuki Yada-Makino, et al.Journal for Immunotherapy of Cancer|April 9, 2022
New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosisShuichi Shinohara, Yusuke Takahashi, Hiroyasu Komuro, et al.Pageof 3